2.1
National policies inform the priorities for medicine topics. The 2019 Department of Health and Social Care voluntary scheme for branded medicines pricing and access requires NICE to issue technology appraisal or highly specialised technologies guidance on all medicines that are new to the UK market or have a significant new therapeutic indication.